Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Member, Board of Directors
Executive Director/President
IAS–USA
Executive Manager
Conference on Retroviruses and Opportunistic Infections (CROI)
San Francisco, California

Current Professional Summary:

Donna M. Jacobsen is the executive director and president of the International Antiviral (formerly AIDS) Society-USA (IAS-USA). She has been responsible for overseeing all aspects of the organization and its activities since it was founded 25 years ago. In her role she also functions as a member of the Board of Directors; as the director of IAS-USA continuing medical education (CME) accreditation, which has the distinction of commendation from the Accreditation Counsel for Continuing Medical Education (ACCME); as the executive editor of the IAS-USA indexed journal, Topics in Antiviral Medicine; and as the primary coordinator of and author on the IAS-USA guidelines for antiretroviral therapy and on resistance and resistance testing (published in the Journal of the American Medical Association and Clinical Infectious Diseases, respectively). Since 2014, Ms Jacobsen has also served as Executive Manager of the Conference on Retroviruses and Opportunistic Infections (CROI). 

Ms Jacobsen has over 30 years of experience in the development and delivery of continuing education and information for clinicians, in medical publishing, and in project management. She became involved in HIV/AIDS in 1985 as a medical editor, when the first effective antiretroviral drug (zidovudine or AZT) was in clinical trials. She is passionate about providing HIV clinicians with state-of-the-art, current, completely unbiased, and relevant information that is based on their educational needs and assists them in providing the very best care for their patients.  Before this work, she was research assistant and cosupervisor of the Laboratory of Molecular Therapeutics at Memorial Sloan-Kettering Cancer Center in New York. Ms Jacobsen received a BS in biology at the State University of New York at Geneseo in 1981.

Committees and Organizations:
  • International AIDS Society (Worldwide) -  1988-Present
  • Alliance for Continuing Medical Education - 1997-Present
  • American Society of Association Executives - 1997-Present
  • American Medical Writers Association - 1985-1990
Education:
  • University of California Course Work (Finance and Accounting) - 1996
  • Golden Gate University Graduate School Course Work (Management of Not-for-Profit Organizations) - 1994
  • State University College at Geneso (BS, Biology) - 1981
Selected Publications:

Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2016 Recommendations of the International Antiviral Society–USA Panel. JAMA. 2016;316(2):191-210.

Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Gunthard HF, Hammer SH, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel. JAMA. 2012;308(4):387-402

Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT; International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304:321-333.

Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008;47:266-285

Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA; International AIDS Society--USA Panel. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. JAMA. 2006;296:827-843.

Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA. Treatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel. JAMA. 2004;292:251-265.
 
Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, Richman DD. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis. 2003;37:113-128.
 
Yeni PG, Hammer SM, Carpenter CCJ, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MA, Jacobsen DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Volberding PA.  Antiretroviral treatment for adult HIV-1 infection in 2002: updated recommendations of the International AIDS Society-USA panel. JAMA. 2002;288:222-235.
 
Gerbert B, Moe JC, Saag MS, Benson CA,  Jacobsen DM,  Feraios A, Hill ME,  Bronstone A, Caspers N, Volberding PA. Toward a definition of HIV expertise.  A survey of experienced HIV physicians. AIDS Patient Care STDS. 2001;15:321-330.
 
Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding, PA. Antiretroviral therapy for HIV infection in adults: updated recommendations of the International AIDS Society-USA panel. JAMA. 2000;283:381-390.

Hirsch MS, Conway B, D'Aquila RT, Johnson VA, Brun-Vezinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM,  Kuritzkes DR, Loveday C, Mellors JW, Vella S, Richman DD. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA panel. JAMA. 2000;283:2417-2426    

Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katezenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding, PA. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA panel. JAMA. 1998;280:78-86.

Hirsch MS, Conway B, D'Aquila RT, Johnson VA, Brun-Vezinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM,  Kuritzkes DR, Loveday C, Mellors JW, Vella S, Richman DD. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society-USA Panel. JAMA. 1998;279:1984-1991.

Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katezenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding, PA.  Antiretroviral therapy for HIV infection in 1997.  Updated recommendations of the International AIDS Society-USA panel.  JAMA. 1997;277(24):1962-1969.
 
Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katezenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding, PA.  Antiretroviral therapy for HIV infection in 1996.  Recommendations of an international panel.  International AIDS Society-USA. JAMA. 1996;276(2):146-154.
 
Saag MS, Holodniy M, Kuritzkes DR, O’Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA.  HIV viral load markers in clinical practice.  Nat Med.  1996;2(6):625-629

Sirotnak FM, Goutas LJ, Jacobsen DM, Mines LS, Barrueco JR, Gaumont Y, Kisliuk RL.  Carrier-mediated transport of folate compounds in LI210 cells.  Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyletrahydrohomofolate in the presence of physiological anions.  Biochem Pharmacol.  1987;36(10):1659-1667.
 
Barrueco JR, Jacobsen DM, Chang CH, Brockman RW, Sirotnak FM.  Proposed mechanism of therapeutic selectivity for 9-beta-D-aribinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.  Cancer Res.  1987;1;47(3):700-706.

Sirotnak FM, Jacobsen DM, Yang CH.  Alteration of folate analogue transport following induced maturation of HL-60 leukemia cells.  Early decline in mediated influx, relationship to commitment, and functional dissociation of entry and exit routes.  J Biol Chem.  1986;261(24):11150-11155. 

Guidelines

Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2016 Recommendations of the International Antiviral Society–USA Panel. JAMA. 2016.